Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nature Pharma Norge AS
AS
Active
Org 925924512
Bekkeveien 163, 3173
Vear
Retail sale of other food
·
NACE 4727
Est. 2020 · 5 years old
1 employees
Monitor
Share
Norway
/
Companies
/
Retail sale of other food
/
Nature Pharma Norge AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
98M
74M
49M
25M
0M
2021: 2M
2M
2021
2022: 9M (+350% vs 2021)
9M
+350%
2022
2023: 28M (+211% vs 2022)
28M
+211%
2023
2024: 46M (+64% vs 2023)
46M
+64%
2024
2025: 79M (+72% vs 2024)
79M
+72%
2025
EBITDA
NOK millions
29M
21M
14M
7M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 5M (+400% vs 2022)
5M
+400%
2023
2024: 8M (+60% vs 2023)
8M
+60%
2024
2025: 23M (+188% vs 2024)
23M
+188%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
79 261
45 882
28 067
8 853
2 392
Staff expenses
−397
−359
−276
−98
−0
EBITDA
23 333
8 021
4 508
669
82
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
23 333
8 021
4 508
669
82
Net financials
482
185
−125
−2
−0
Profit before tax
23 815
8 206
4 383
667
82
Tax
5 244
1 812
883
206
37
Net profit
18 571
6 394
3 500
460
45
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
28 377
16 659
7 254
2 597
1 201
Equity
19 030
10 459
4 065
566
105
Long-term debt
1 299
725
0
820
820
Short-term debt
8 048
5 475
3 189
1 211
276
Total debt
9 347
6 200
3 189
2 031
1 096
Financial ratios
5-year trend
EBITDA margin
29,4 %
This company
15,8 %
Market median
This company
Market median
86% above market
2021
2025
Equity ratio
67,1 %
This company
38,2 %
Market median
This company
Market median
76% above market
2021
2025
Return on equity
97,6 %
This company
18,4 %
Market median
This company
Market median
430% above market
2021
2025
Net profit margin
23,4 %
This company
8,1 %
Market median
This company
Market median
189% above market
2021
2025
Asset turnover
2,79×
This company
1,12×
Market median
This company
Market median
149% above market
2021
2025
Debt / equity
0,49×
This company
0,62×
Market median
This company
Market median
21% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nature Pharma Norge AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
